Search Results - "Roskosz, J."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Estimation of Risk of Inherited Medullary Thyroid Carcinoma in Apparent Sporadic Patients by WIENCH, M, WYGODA, Z, ZEMAN, M, ROSKOSZ, J, KUKULSKA, A, KRAWCZYK, Z, JARZAB, B, GUBALA, E, WLOCH, J, LISOWSKA, K, KRASSOWSKI, J, SCIEGLINSKA, D, FISZER-KIERZKOWSKA, A, LANGE, D, KULA, D

    Published in Journal of clinical oncology (01-03-2001)
    “…The study was undertaken to evaluate the frequency of inherited medullary thyroid carcinoma (MTC) among patients with apparent sporadic disease. A stepwise…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Risk of malignant tumors in first-degree relatives of patients with differentiated thyroid cancer -- a hospital based study by Handkiewcz-Junak, D, Banasik, T, Kolosza, Z, Roskosz, J, Kukulska, A, Puch, Z, Jarzab, B

    Published in Neoplasma (2006)
    “…In presented study the risk of incidence of familial differentiated thyroid cancer as well as the risk of other malignant tumors in families of DTC patients…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6

    Efficacy and safety of radioiodine in the treatment of disseminated differentiated thyroid cancer (DTC) in children by Handkiewicz-Junak, D., Roskosz, J., Kropinska, A., Kozielski, J., Krzywiecki, A., Krajewska, J., Puch, Z., Olczyk, T., Jarzab, B.

    Published in Journal of clinical oncology (20-05-2009)
    “…Abstract only 10065 Background: Distant metastases, mainly to lung are diagnosed in about 20% of children with DTC. At present radioiodine is the treatment of…”
    Get full text
    Journal Article
  7. 7

    Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children by Jarzab, B, Handkiewicz Junak, D, Włoch, J, Kalemba, B, Roskosz, J, Kukulska, A, Puch, Z

    Published in European journal of nuclear medicine (01-07-2000)
    “…At most centres, the standard treatment for differentiated thyroid cancer (DTC) comprises total thyroidectomy, radioiodine treatment and thyroid-stimulating…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Use of recombinant human TSH for stimulation of iodine radioisotope uptake in metastases of thyroid cancer during therapy with 131I by Roskosz, J, Handkiewicz-Junak, D, Turska, M, Wygoda, Z, Jurecka-Tuleja, B, Jarzab, B

    Published in Wiadomości lekarskie (1960) (2001)
    “…The diagnostics with the use of recombinant human TSH for the follow-up of differentiated thyroid carcinoma (DTC) has been already approved. In more than 400…”
    Get more information
    Journal Article
  10. 10

    Use of 13-cis retinoic acid for treatment of advanced differentiated thyroid cancer by Handkiewicz-Junak, D, Roskosz, J, Turska, M, Wygoda, Z, Jarzab, B

    Published in Wiadomości lekarskie (1960) (2001)
    “…Retinoids, a large group of compounds structurally related to vitamin A, are able to induce redifferentiation of thyroid cancer cells. The aim of the study is…”
    Get more information
    Journal Article
  11. 11

    L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression by Kowalczyk, P, Roskosz, J, Jurecka-Tuleja, B, Gubała, E, Czernik, E, Jarzab, B

    Published in Wiadomości lekarskie (1960) (2001)
    “…Life-time L-thyroxine therapy is obligatory in patients treated for differentiated thyroid carcinoma (DTC) in order to suppress serum TSH. The rationale for…”
    Get more information
    Journal Article
  12. 12

    Evaluation of effects of L-thyroxine therapy in differentiated thyroid carcinoma on the cardiovascular system --prospective study by Matuszewska, G, Roskosz, J, Włoch, J, Jurecka-Tuleja, B, Hasse-Lazar, K, Kowalczyk, P, Jarzab, B

    Published in Wiadomości lekarskie (1960) (2001)
    “…Patients with differentiated thyroid carcinoma are treated by thyreoidectomy, followed by radioiodine treatment. A life-time suppressive therapy with…”
    Get more information
    Journal Article
  13. 13

    Effects of L-thyroxine suppressive therapy on cardiac mass in patients with differentiated thyroid cancer by Kowalczyk, P, Sielańczyk, A, Nowak, J, Matuszewska, G, Roskosz, J, Czernik, E, Gubała, E, Jarzab, B

    Published in Polskie archiwum medycyny wewne̦trznej (01-02-2001)
    “…Patients with differentiated thyroid carcinoma (DTC) receive a life time l-thyroxine therapy in suppressive doses and may exhibit signs of cardiac hypertrophy…”
    Get more information
    Journal Article
  14. 14

    Early evaluation of treatment effectiveness using 131I iodine radiotherapy in patients with differentiated thyroid cancer by Gawkowska-Suwińska, M, Turska, M, Roskosz, J, Puch, Z, Jurecka-Tuleja, B, Handkiewicz-Junak, D, Wygoda, Z, Jarzab, B

    Published in Wiadomości lekarskie (1960) (2001)
    “…This paper presents the preliminary results of a prospective randomized trial on early effectiveness of 30 mCi versus 60 mCi for ablation of thyroid remnants…”
    Get more information
    Journal Article
  15. 15

    Recombinant human TSH for the treatment of differentiated thyroid cancer metastatic to the spine by Jarzab, B, Roskosz, J, Gawkowska-Suwińska, M, Turska, M, Handkiewicz-Junak, D, Puch, Z, Wygoda, Z, Zajusz, A

    “…The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (DTC) is already approved, however its application in (131)I…”
    Get full text
    Journal Article
  16. 16

    The usefulness of MIBI scintigraphy for postoperative monitoring of patients with thyroid cancer by Puch, Z, Handkiewicz-Junak, D, Zajusz, A, Orlef, A, Roskosz, J, Jarzab, B

    Published in Polskie archiwum medycyny wewne̦trznej (01-03-1999)
    “…Metoxyizobutyloizonitrile labelled with technetium 99mTc is a radio-pharmaceutical that was shown to accumulate in benign and cancerous thyroid tissue. As it…”
    Get more information
    Journal Article